カテゴリー： 世界, 医療/バイオ, Grand View Research

世界の前臨床イメージング市場（2023-2030）：製品別（CTイメージング、サービス、超音波イメージング）、用途別（研究開発、創薬）、最終用途別、地域別

【英語タイトル】Preclinical Imaging Market Size, Share & Trends Analysis Report By Product (CT Imaging, Services, Ultrasound Imaging), By Application (Research and Development, Drug Discovery), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV232）・商品コード：GRV23NOV232
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

前臨床イメージング市場の成長と動向
Grand View Research社の最新レポートによると、世界の前臨床イメージング市場規模は2030年までに59億5000万米ドルに達すると予測されています。2023年から2030年にかけての年平均成長率は4.74%と予測されています。研究開発への多額の投資は、世界中の研究プロジェクトを後押ししています。その結果、前臨床イメージングの需要は着実に増加しています。製薬、バイオテクノロジー、ライフサイエンス、医療機器、化粧品は、研究開発においてイメージングモダリティが広く使用されている応用分野です。さらに、動物病院や教育機関もこの市場に新たな需要を生み出しています。

核医学技術（主に陽電子放射断層撮影法（PET）と単一光子放射コンピュータ断層撮影法（SPECT））、光学イメージング、マイクロコンピュータ断層撮影法（CT）、マイクロ磁気共鳴画像法（MRI）、光音響トモグラフィ（PAT）、超音波は、小動物の生体内イメージング用途に最も適したモダリティです。各モダリティにはそれぞれ利点と欠点があります。研究対象の病態生理学的プロセスに関する補完的な情報を提供するために設計されたマルチモダリティ装置は、各イメージングモダリティ固有の限界を克服することを目指し、急速に普及しています。micro-CTやmicro-MRIのような高解像度モダリティと、micro-PETやmicro-SPECTのような機能的情報を提供する高感度技術の組み合わせは、感染症、腫瘍学、循環器学、神経学などの主要分野における研究の視野を広げ、疾患の根本的なメカニズムの理解に貢献するだけでなく、新規化学物質を評価するための効率的かつ統一的なツールを提供することが期待されています。新規化合物や新薬候補を評価するための効率的で統一されたツールを提供し、世界市場の成長を後押ししています。

世界市場の競合各社は、新製品の上市や製造能力の強化など、製品ポートフォリオの充実に向けてさまざまな取り組みを行っています。例えば、2023年2月に開催された第75回インド放射線画像学会（Indian Radiological and Imaging Association）において、FUJIFILM Indiaは機器とサービスの開発を発表しました。同社は2023年2月2日から5日までアムリトサルで開催されたイベントで、最先端の診断ツールのデモンストレーションを行いました。最近発売されたMRI装置APERTO Lucent Non DICOMプリンターAPEOS、超音波診断装置Arietta 650 DeepInsightおよびArietta 850 DeepInsightは、すべて新しいポートフォリオの構成要素です。また、スマートフォン向けアプリケーション「FUJIFILM Connect」もリリースしています。

さらに、がん研究・調査のアプリケーションに使用される高スループット超音波イメージングシステムの進歩が市場を後押ししています。2022年4月、パーキンエルマーがライブ画像解析の拡充を発表したことを受け、がん、腎臓・肝臓病、心臓病などの分野で非侵襲的な臨床研究や創薬を加速できる、完全自動化技術とハイスループット能力を備えたハンドヘルド超音波イメージングシステム「Vega（ベガ）」を発売しました。非侵襲的なイメージング法は、侵襲的な手術の必要性を減らし、動物の不快感を最小限に抑えることができるため、その使用が推奨されています。前臨床イメージング技術は、このような倫理的配慮の結果として採用されています。

前臨床イメージング市場レポートハイライト

- 製品別では、光学イメージングセグメントが、小動物イメージングや新薬探索プロジェクトでの幅広い利用により、2022年に13.6%の最大収益シェアを獲得しました。

- アプリケーション別では、技術進歩や医療インフラの改善により、研究開発分野が2022年に54.93%の最大収益シェアを獲得しました。

- 最終用途別では、製薬・バイオテクノロジー企業が2022年に40.19%の最大収益シェアを占めました。製薬・バイオテクノロジー企業における絶え間ない研究活動と製品の革新が、市場プレイヤーの製品販売を増加させ、市場成長を牽引しています。

- 地域別では、北米が2022年に最大の収益シェアを占めました。これは、研究インフラが発達していること、前臨床プロジェクトが多いこと、技術的に高度なデバイスの採用率が高いことなどが要因です。

- 業界の主要企業は、人工知能対応システムなどの先進技術や機能の投入に注力しています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界の前臨床イメージング市場：製品別予測・動向分析
第5章. 世界の前臨床イメージング市場：用途別予測・動向分析
第6章. 世界の前臨床イメージング市場：エンドユーザー別予測・動向分析
第7章. 世界の前臨床イメージング市場：地域別予測・動向分析
第8章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Preclinical Imaging Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Technological advancements
3.4.1.2. Growing number of investments and funding in research and development
3.4.2. Market restraint analysis
3.4.2.1. Strict regulatory framework
3.5. Preclinical Imaging Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Preclinical Imaging Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. CT Imaging
4.1.2. MRI Imaging
4.1.3. PET/SPECT Imaging
4.1.4. Multi-modal Imaging
4.1.5. Optical Imaging
4.1.6. Ultrasound Imaging
4.1.7. Photoacoustic Imaging
4.1.8. Reagents
4.1.9. Services
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Preclinical Imaging Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. CT imaging
4.5.1.1. CT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. MRI imaging
4.5.2.1. MRI imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. PET/SPECT imaging
4.5.3.1. PET/SPECT imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Multi-modal imaging
4.5.4.1. Multi-modal imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.5. Optical imaging
4.5.5.1. Optical imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.6. Ultrasound imaging
4.5.6.1. Ultrasound imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.7. Photoacoustic imaging
4.5.7.1. Photoacoustic imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.8. Reagents
4.5.8.1. Reagents imaging market estimates and forecast 2018 to 2030 (USD Million)
4.5.9. Services
4.5.9.1. Services market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Preclinical Imaging Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Research and Development
5.1.2. Drug Discovery
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Preclinical Imaging Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Research and Development
5.5.1.1. Research and development market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Drug Discovery
5.5.2.1. Drug discovery market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Preclinical Imaging Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Pharma and Biotech Companies
6.1.2. Research Institutes
6.1.3. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Preclinical Imaging Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Pharma and Biotech Companies
6.5.1.1. Pharma and biotech companies market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Research Institutes
6.5.2.1. Research institutes market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Others
6.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Preclinical Imaging Market: Regional Estimates & Trend Analysis
7.1. Regional market share analysis, 2020 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
7.7. North America
7.7.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8. Europe
7.8.1. UK
7.8.1.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.6. Sweden
7.8.6.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.7. Norway
7.8.7.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.8.8. Denmark
7.8.8.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.4. South Korea
7.9.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.5. Australia
7.9.5.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.6. Thailand
7.9.6.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.9.6.2.
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.11. MEA
7.11.1. Saudi Arabia
7.11.1.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.11.2. South Africa
7.11.2.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2018 – 2030 (USD Million)
7.11.4. Kuwait
7.11.4.1. Market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Bruker Corporation
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Siemens Healthineers AG
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. GE Healthcare
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. TriFoil Imaging
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. PerkinElmer, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. VisualSonic Inc. (Fujifilm)
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Mediso Ltd.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Agilent Technologies
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. MR Solutions
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. MILabs B.V.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
8.3.14. Molecubes
8.3.14.1. Company overview
8.3.14.2. Financial performance
8.3.14.3. Product benchmarking
8.3.14.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 3 North America preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 4 North America preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 5 North America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 6 U.S. preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 9 Canada preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 10 Canada preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 11 Canada preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 12 Europe preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 13 Europe preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 14 Europe preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 15 Europe preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 16 Germany preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 17 Germany preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 18 Germany preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 19 UK preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 20 UK preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 21 UK preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 22 France preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 23 France preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 24 France preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 25 Italy preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 26 Italy preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 27 Italy preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 28 Spain preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 29 Spain preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 30 Spain preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 31 Sweden preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 32 Sweden preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 33 Sweden preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 34 Denmark preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 35 Denmark preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 37 Norway preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 38 Norway preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 39 Norway preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 40 Asia Pacific preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 41 Asia Pacific preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 42 Asia Pacific preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 44 China preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 45 China preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 46 China preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 47 Japan preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 48 Japan preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 49 Japan preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 50 India preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 51 India preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 52 India preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 53 Australia preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 54 Australia preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 55 Australia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 56 South Korea preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 57 South Korea preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 58 South Korea preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 59 Thailand preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 60 Thailand preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 62 Latin America preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 63 Latin America preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 64 Latin America preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 66 Brazil preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 68 Brazil preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 69 Mexico preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 71 Mexico preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 72 Argentina preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa preclinical imaging market, by region, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 79 South Africa preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 85 UAE preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 86 UAE preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 87 UAE preclinical imaging market, by end-use, 2018 - 2030 (USD Million)
Table 88 Kuwait preclinical imaging market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait preclinical imaging market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait preclinical imaging market, by end-use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Preclinical imaging market: market outlook
Fig. 14 Preclinical imaging market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Preclinical imaging market driver impact
Fig. 20 Preclinical imaging market restraint impact
Fig. 21 Preclinical imaging market strategic initiatives analysis
Fig. 22 Preclinical imaging market: product movement analysis
Fig. 23 Preclinical imaging market: product outlook and key takeaways
Fig. 24 CT market estimates and forecast, 2018 - 2030
Fig. 25 MRI market estimates and forecast, 2018 - 2030
Fig. 26 PET/SPECT market estimates and forecast, 2018 - 2030
Fig. 27 Multi-Modal market estimates and forecast, 2018 - 2030
Fig. 28 Optical market estimates and forecast, 2018 - 2030
Fig. 29 Ultrasound market estimates and forecast, 2018 - 2030
Fig. 30 Photoacoustic market estimates and forecast, 2018 - 2030
Fig. 31 Reagents market estimates and forecast, 2018 - 2030
Fig. 32 Services market estimates and forecast, 2018 - 2030
Fig. 33 Preclinical imaging market: application movement analysis
Fig. 34 Preclinical imaging market: application outlook and key takeaways
Fig. 35 Research and development market estimates and forecast, 2018 - 2030
Fig. 36 Drug discovery market estimates and forecast, 2018 - 2030
Fig. 37 Preclinical imaging market: end-use movement analysis
Fig. 38 Preclinical imaging market: end-use outlook and key takeaways
Fig. 39 Pharma and biotech companies market estimates and forecast, 2018 - 2030
Fig. 40 Research institutes market estimates and forecast, 2018 - 2030
Fig. 41 Others market estimates and forecast, 2018 - 2030
Fig. 42 Global preclinical imaging market: regional movement analysis
Fig. 43 Global preclinical imaging market: regional outlook and key takeaways
Fig. 44 Global market shares and leading players
Fig. 45 North America market share and leading players
Fig. 46 Europe market share and leading players
Fig. 47 Asia Pacific market share and leading players
Fig. 48 Latin America market share and leading players
Fig. 49 Middle East & Africa market share and leading players
Fig. 50 North America: SWOT
Fig. 51 Europe SWOT
Fig. 52 Asia Pacific SWOT
Fig. 53 Latin America SWOT
Fig. 54 MEA SWOT
Fig. 55 North America, by country
Fig. 56 North America
Fig. 57 North America market estimates and forecast, 2018 - 2030
Fig. 58 U.S.
Fig. 59 U.S. market estimates and forecast, 2018 - 2030
Fig. 60 Canada
Fig. 61 Canada market estimates and forecast, 2018 - 2030
Fig. 62 Europe
Fig. 63 Europe. market estimates and forecast, 2018 - 2030
Fig. 64 UK
Fig. 65 UK market estimates and forecast, 2018 - 2030
Fig. 66 Germany
Fig. 67 Germany market estimates and forecast, 2018 - 2030
Fig. 68 France
Fig. 69 France market estimates and forecast, 2018 - 2030
Fig. 70 Italy
Fig. 71 Italy market estimates and forecast, 2018 - 2030
Fig. 72 Spain
Fig. 73 Spain market estimates and forecast, 2018 - 2030
Fig. 74 Sweden
Fig. 75 Sweden market estimates and forecast, 2018 - 2030
Fig. 76 Denmark
Fig. 77 Denmark market estimates and forecast, 2018 - 2030
Fig. 78 Norway
Fig. 79 Norway market estimates and forecast, 2018 - 2030
Fig. 80 Asia Pacific
Fig. 81 Asia Pacific market estimates and forecast, 2018 - 2030
Fig. 82 China
Fig. 83 China market estimates and forecast, 2018 - 2030
Fig. 84 Japan
Fig. 85 Japan market estimates and forecast, 2018 - 2030
Fig. 86 India
Fig. 87 India market estimates and forecast, 2018 - 2030
Fig. 88 Australia
Fig. 89 Australia market estimates and forecast, 2018 - 2030
Fig. 90 South Korea
Fig. 91 South Korea market estimates and forecast, 2018 - 2030
Fig. 92 Thailand
Fig. 93 Thailand market estimates and forecast, 2018 - 2030
Fig. 94 Latin America
Fig. 95 Latin America market estimates and forecast, 2018 - 2030
Fig. 96 Brazil
Fig. 97 Brazil market estimates and forecast, 2018 - 2030
Fig. 98 Mexico
Fig. 99 Mexico market estimates and forecast, 2018 - 2030
Fig. 100 Argentina
Fig. 101 Argentina market estimates and forecast, 2018 - 2030
Fig. 102 Middle East and Africa
Fig. 103 Middle East and Africa. market estimates and forecast, 2018 - 2030
Fig. 104 Saudi Arabia
Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
Fig. 106 South Africa
Fig. 107 South Africa market estimates and forecast, 2018 - 2030
Fig. 108 UAE
Fig. 109 UAE market estimates and forecast, 2018 - 2030
Fig. 110 Kuwait
Fig. 111 Kuwait market estimates and forecast, 2018 - 2030
Fig. 112 Participant categorization- preclinical imaging market
Fig. 113 Market share of key market players- preclinical imaging market

★調査レポート[世界の前臨床イメージング市場（2023-2030）：製品別（CTイメージング、サービス、超音波イメージング）、用途別（研究開発、創薬）、最終用途別、地域別] (コード：GRV23NOV232)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の前臨床イメージング市場（2023-2030）：製品別（CTイメージング、サービス、超音波イメージング）、用途別（研究開発、創薬）、最終用途別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の組織クリアリング市場（2023-2030）：製品別（器具、キット＆試薬、サービス）、組織種類別（軟組織、硬組織）、用途別、最終用途別、地域別
  • 世界のスキンケアデバイス市場（2023-2030）：製品別、用途別（診断デバイス、治療デバイス）、最終用途別、地域別
  • 世界の女性健康診断市場（2023-2030）：最終用途別、用途別（癌、感染症、骨粗鬆症、妊娠・不妊、出生前）、地域別
  • 世界の光線療法機器市場（2023-2030）：製品別（従来型光線治療器）、用途別（皮膚疾患治療）、最終用途別、地域別
  • 世界の湿潤創傷被覆材市場（2023-2030）：製品別（フォーム被覆材、フィルム被覆材）、用途別、最終用途別、地域別
  • 世界の卵巣がん治療薬市場（2023-2030）：治療クラス別（PARP、PD-L1、血管新生阻害剤）、治療法別、最終用途別、地域別
  • 世界のソフトジェルカプセル市場（2023-2030）：種類別（ゼラチンベース／動物性、非動物性）、用途別、最終用途別、地域別
  • 食品受託製造のグローバル市場2023-2030：製造、包装、カスタム処方、研究開発
  • 世界の外科用レトラクター市場（2023-2030）：種類別（ハンドヘルド型、自己保持型）、製品別（腹部レトラクター、フィンガーレトラクター）、用途別（脳神経外科、産婦人科）、最終用途別、地域別
  • 世界のウイルスろ過市場（2023-2030）：製品別、技術別（ろ過、クロマトグラフィー）、用途別（生物学、医療機器、浄水）、最終用途別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆